Arrayit Corporation (OTC: ARYC), a developer, manufacturer and marketer of proprietary life sciences technologies and consumables for disease prevention, announces that its representative met with the CEO of DHK Medical India. The meeting was held in California. Following the meeting, ARYC expects to do significant business with DHK Medical. In the first year, the company expects selling tests worth some $3 million. This is likely to increase to $5 million in the second year and $8 million in the third year. After the first 3 years, potential annual sales could be $10 million. ARYC will be meeting with DHK Medical’s CEO once again.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
